Saturday, July 11, 2026

pharma · Lymphoma

Sinobioway Cell Therapy

Sinobioway Cell Therapy clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
8
Patents
0
Intelligence · Clinical Programs

Sinobioway Cell Therapy projects

1 ClinicalTrials.gov programs sponsored by Sinobioway Cell Therapy.

Sinobioway Cell Therapy has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. The Chimeric Antigen Receptor T Cell Immunotherapy (CAR-T)

    Sinobioway Cell Therapy Co.,

    Lymphoma

    phase 1 mab active

    1 trial

Frequently asked questions

How many clinical projects does Sinobioway Cell Therapy have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.